Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Bibliographic Details
Main Authors:	Ziberna, K, Recalde, A, Carnicer, R, Casadei, B
Format:	Conference item
Published:	Springer Berlin Heidelberg 2016

Similar Items

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
by: Mighiu, AS, et al.
Published: (2021)

Role of diabetes mellitus in atrial fibrillation and potential new treatments
by: Ziberna, K
Published: (2020)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
by: Mighiu, A, et al.
Published: (2017)

Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
by: Simon, J, et al.
Published: (2016)

BH4 supplementation as a new treatment for diabetic cardiomyopathy
by: Carnicer, R, et al.
Published: (2019)

Identification of patients with atrial fibrillation: a big data exploratory analysis of the UK Biobank
by: Oster, J, et al.
Published: (2020)

Catheter ablation of atrial fibrillation in patients with diabetes mellitus
by: Allen Wang, MD, et al.
Published: (2020-08-01)

Reduced nitric oxide bioactivity increases platelet activation in mice with streptozotocin-induced diabetes mellitus
by: Schafer, A, et al.
Published: (2003)

Stages of development of streptozotocin-induced experimental diabetes mellitus
by: T. M. Boychuk, et al.
Published: (2017-09-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
by: T. M. Boychuk, et al.
Published: (2017-09-01)

Mechanisms of atrial fibrillation
by: Wijesurendra, RS, et al.
Published: (2019)

Effects of Electrical Remodeling on Atrial Fibrillation in Diabetes Mellitus
by: Ling-ling Qian, et al.
Published: (2023-01-01)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
by: Andreas S. Papazoglou, et al.
Published: (2021-02-01)

BH4 increases nNOS Activity and preserves left ventricular function in diabetes
by: Carnicer Hijazo, R, et al.
Published: (2021)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice
by: Narumi Takahashi, et al.
Published: (2024-01-01)

Streptozotocin-induced diabetes mellitus affects lysosomal enzymes in rat liver
by: G.B. Peres, et al.
Published: (2014-06-01)

Streptozotocin model of stable diabetes mellitus
by: G. N. Skaletskaya, et al.
Published: (2019-01-01)

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
by: R. Gimenes, et al.
Published: (2018-01-01)

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
by: Loryn J. Bohne, et al.
Published: (2019-02-01)

How to risk stratify new‐onset atrial fibrillation in patients with hypertension and diabetes mellitus
by: Naoya Kataoka, et al.
Published: (2024-02-01)

The incidence of atrial fibrillation in type 2 diabetes mellitus patients
by: Jandrić-Kočič Marijana
Published: (2020-01-01)

Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?
by: Ana Lorenzo-Almorós, et al.
Published: (2023-04-01)

The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation
by: Denise Guckel, et al.
Published: (2021-10-01)

ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN
by: Alexey D. Ehrlich
Published: (2018-12-01)

Endurance swimming and increased risk of atrial fibrillation
by: Andrew D. Schreiner, et al.
Published: (2016-06-01)

Morphology of bronchial epithelium in rodent streptozotocin-induced diabetes mellitus
by: Oksana Anatolyevna Pivovarova, et al.
Published: (2013-12-01)

Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man
by: Reilly, S, et al.
Published: (2015)

Evaluation of plasma homocysteine status in streptozotocin induced-diabetes mellitus in rabbit
by: K Azimzadeh, et al.
Published: (2009-08-01)

Seek and ye shall find… subclinical atrial fibrillation in high-risk elderly patients.
by: Wijesurendra, R, et al.
Published: (2017)

Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death
by: Edwin A. Homan, et al.
Published: (2019-01-01)

Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study
by: JungMin Choi, et al.
Published: (2023-01-01)

Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-03-01)

Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
by: Alexander Kogan, et al.
Published: (2023-03-01)

OSC16: Effects of streptozotocin-induced diabetes mellitus on peri-implantitis
by: ..
Published: (2018-01-01)

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
by: Hyun-Jung Lee, et al.
Published: (2020-06-01)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
by: Reilly, S, et al.
Published: (2009)

Administration of Selenium Decreases Lipid Peroxidation and Increases Vascular Endothelial Growth Factor in Streptozotocin Induced Diabetes Mellitus
by: Pervin Vural, et al.
Published: (2017-08-01)

Is increased myocardial oxidative stress an early event in the natural history of atrial fibrillation?
by: Reilly, S, et al.
Published: (2007)

Electrical Conduction System Remodeling in Streptozotocin-Induced Diabetes Mellitus Rat Heart
by: Yu Zhang, et al.
Published: (2019-07-01)

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction
by: Jodi D. Edwards, et al.
Published: (2020-06-01)